Next 10 |
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate i...
2024-04-22 11:18:39 ET Summary The Simplify Propel Opportunities ETF (SURI) is a healthcare-based fund that provides exposure to global fixed income and equity markets in the healthcare sector. SURI has a since-inception return of -13%, but its recent performance has shown potenti...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the appointment of Dale ...
2024-04-07 03:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-05 16:42:08 ET Gainers: Applied Optoelectronics ( AAOI ) +4% . Outset Medical ( OM ) +2% . SunPower Corporation ( SPWR ) +2% . Applied Therapeutics ( APLT ) +2% . Enovix Corporation ( ENVX ) +2% . Losers: Palladyn...
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will present ful...
2024-03-28 17:01:46 ET More on Applied Therapeutics Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade) ARISE-HF Phase 3 Trial Likely To Disappoint Due To...
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the U.S. Food and D...
2024-03-22 16:43:28 ET More on Applied Therapeutics Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade) Read the full article on Seeking Alpha For...
2024-03-06 07:31:25 ET More on Applied Therapeutics Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade) ARISE-HF Phase 3 Trial Likely To Disappoint Due To...
News, Short Squeeze, Breakout and More Instantly...
Applied Therapeutics Inc. Company Name:
APLT Stock Symbol:
NYSE Market:
Applied Therapeutics Inc. Website:
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate i...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company developing a p...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the appointment of Dale ...